Recruitment of Orc6l, a dormant maternal mRNA in mouse oocytes, is essential for DNA replication in 1-cell embryos  by Murai, Shin et al.
Developmental Biology 341 (2010) 205–212
Contents lists available at ScienceDirect
Developmental Biology
j ourna l homepage: www.e lsev ie r.com/deve lopmenta lb io logyRecruitment of Orc6l, a dormant maternal mRNA in mouse oocytes, is essential for
DNA replication in 1-cell embryos
Shin Murai a,1, Paula Stein a, Mariano G. Buffone a,2, Shigeru Yamashita b, Richard M. Schultz a,⁎
a Department of Biology, University of Pennsylvania, Philadelphia, PA 19104-6018, USA
b Department of Biochemistry, Toho University School of Medicine, 5-21-16 Omorinishi Otaku, Tokyo, 143-8540, Japan⁎ Corresponding author. Department of Biology, Un
South University Avenue, Philadelphia, PA 19104-6018,
E-mail addresses: mryshin@med.toho-u.ac.jp (S. Mur
marianob@mail.med.upenn.edu (M.G. Buffone), rschultz@
1 Present address: Department of Biochemistry, Toho
5-21-16 Omorinishi Otaku, Tokyo, 143-8540, Japan.
2 Present address: Center for Research on Reprod
University of Pennsylvania School of Medicine, 421 Cur
19104-6160, USA.
0012-1606/$ – see front matter © 2010 Elsevier Inc. A
doi:10.1016/j.ydbio.2010.02.027a b s t r a c ta r t i c l e i n f oArticle history:
Received for publication 20 November 2009
Revised 18 February 2010
Accepted 19 February 2010
Available online 26 February 2010
Keywords:
DNA replication
Dormant maternal mRNA
Cytoplasmic polyadenylation element
Mouse oocyte
Mouse 1-cell embryoMouse oocytes acquire the ability to replicate DNA during meiotic maturation, presumably to ensure that
DNA replication does not occur precociously between MI and MII and only after fertilization. Acquisition of
DNA replication competence requires protein synthesis, but the identity of the proteins required for DNA
replication is poorly described. In Xenopus, the only component missing for DNA replication competence is
CDC6, which is synthesized from a dormant maternal mRNA recruited during oocyte maturation, and a
similar situation also occurs during mouse oocyte maturation. We report that ORC6L is another component
required for acquisition of DNA replication competence that is absent in mouse oocytes. The dormant
maternal Orc6l mRNA is recruited during maturation via a CPE present in its 3′ UTR. RNAi-mediated ablation
of maternal Orc6l mRNA prevents the maturation-associated increase in ORC6L protein and inhibits DNA
replication in 1-cell embryos. These results suggest that mammalian oocytes have more complex mecha-
nisms to establish DNA replication competence when compared to their Xenopus counterparts.iversity of Pennsylvania, 433
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Somatic cells have developed sophisticated mechanisms to regu-
late assembly of pre-replication complexes (preRC), license the ability
of an origin of replication (ORI) to initiate DNA synthesis, and prevent
re-replication of DNA (DePamphilis, 2003, 2005; DePamphilis et al.,
2006). During the M to G1 transition, preRCs are assembled, which
entails the assembly of an ORI that is composed of ORC1–6 at
many sites in the genome. CDC6 and CDT1 are next recruited to these
ORC:chromatin sites and in turn recruit an MCM complex composed
of MCM2–7, a DNA helicase. Recruitment of MCM is termed rep-
lication licensing because the origin recognition complex (ORC) is
now capable of supporting DNA replication. Licensing occurs in an
environment of low cyclin-dependent protein kinase (CDK) activity.
DNA synthesis is initiated by the further addition of MCM10 and the
action of protein kinases, including CDKs, namely, CDK2 associated
with either cyclin A or E. Once DNA replication has initiated following
recruitment of CDC45 that in turn recruits DNA polymerase-α and
DNA primase, re-replication of DNA is prevented by CDKs inhibitingthe function of ORCs, CDC6, CDT1 and MCM, thus linking cell cycle
progression with DNA replication.
In contrast to somatic cells, oocytes are arrested in the ﬁrst meiotic
prophase and have lost the ability to replicate DNA, ensuring that they
maintain a 4C chromosome content. The ability to initiate DNA rep-
lication is acquired during oocyte maturation around MI and requires
protein synthesis, but DNA replication does not occur until following
fertilization or egg activation (Furuno et al., 1994). High levels of
CDK1/CDC2A activity are required to maintain metaphase II arrest
that in turn inhibits DNA replication (Furuno et al., 1994). The
maturation-associated recruitment of Mos mRNA results in synthesis
of MOS that is essential to maintain elevated levels of CDK1/CDC2A
activity that in turn is required to maintain metaphase arrest
(Colledge et al., 1994; Hashimoto et al., 1994). Inhibiting synthesis
of MOS during maturation of Xenopus oocytes results in maturing
oocytes entering interphase and replicating DNA soon after MI
(Furuno et al., 1994). Entry into interphase is presumably because
CDK1/CDC2A activity decreases, thereby relieving ORIs from their
inhibited state as well as permitting formation of a nuclear membrane
that is essential for DNA replication.
Xenopus oocytes contain all of the proteins required to assemble
and license an ORI except for CDC6. Recruitment of Cdc6mRNA during
maturation leads to the synthesis of CDC6 protein and restoration of
the ability of the cytoplasm to support DNA replication (Lemaitre
et al., 2002; Whitmire et al., 2002), i.e., synthesis of CDC6 can solely
account for the protein synthesis requirement for acquisition of
DNA replication competence during oocyte maturation. For example,
blocking the maturation-associated increase in CDC6 protein by
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maturation blocks DNA replication. DNA replication competence is
restored, however, when CDC6 protein is also injected (Lemaitre et al.,
2002).
Mouse oocytes also lack CDC6 protein and amaturation-associated
recruitment of Cdc6 mRNA results in CDC6 protein accumulation by
MII (Anger et al., 2005; Lemaitre et al., 2004). A role for newly
synthesized CDC6 in DNA replication following fertilization or egg
activation could not be established because RNAi-mediated ablation
of Cdc6 mRNA inhibited oocyte maturation; oocytes underwent
germinal vesicle breakdown but a spindle did not form and although
chromosomes condensed, they did not form visible bivalents (Anger
et al., 2005). Thus, whether recruitment of Cdc6 mRNA is solely
responsible for the maturation-associated acquisition of replication
competence, as it is in Xenopus oocytes, remains an open question.
We had previously conducted microarray studies on mouse
oocytes and 1-cell embryos and found that the relative abundance
of several transcripts is increased in 1-cell embryos relative to oocytes,
presumably due to polyadenylation because there is no transcription
during this time and poly dT was used to prime the reverse tran-
scription reaction (Zeng et al., 2004; Zeng and Schultz, 2005). We
noted that the relative abundance of Orc6l mRNA was increased,
making it another candidate whose recruitment would contribute to
the maturation-associated acquisition of replication competence. We
report here that ORC6L protein is undetectable in oocytes but present
in metaphase II-arrested eggs due to a cytoplasmic polyadenylation
element (CPE)-mediated recruitment of Orc6l mRNA. RNAi-mediated
ablation of Orc6l mRNA prevents accumulation of ORC6L protein
in metaphase II eggs and inhibits DNA replication following egg
activation.Materials and methods
Isolation and culture of oocytes and embryos
Full-grown, germinal vesicle intact oocytes (GV) were obtained
from pregnant mare serum gonadotropin (PMSG)-primed, 6 week-
old, CF-1 femalemice (Harlan, Indianapolis, IN) and freed of attached
cumulus cells as previously described (Schultz et al., 1983). Germinal
vesicle breakdown (GVBD)was inhibited by adding 2.5 μMmilrinone
to the isolation and culture media (Tsafriri et al., 1996). The
collection medium was bicarbonate-free minimal essential medium
(Earle's salts) supplemented with 3 mg/ml of polyvinylpyrrolidone
(PVP) and 25 mM Hepes (pH 7.3) (MEM-PVP). After collection,
oocytes were cultured in CZB medium (Chatot et al., 1989) con-
taining milrinone.
For isolation of metaphase II eggs (MII eggs) and 1-cell embryos,
CF-1 female mice were superovulated with the injection of 5 IU of
PMSG, followed 48 h later by 5 IU of human chorionic gonadotropin
(hCG). MII eggs were collected 13–16 h post-hCG administration.
For generation of 1-cell embryos, after hCG injection the females
were mated with B6D2F1/J male mice (Jackson Lab, Bar Harbor, ME)
and embryos were collected 20–24 h after hCG. The cumulus cells
were removed by a brief hyaluronidase treatment (3 mg/ml). One-
cell embryos were cultured in 10-μl drops of KSOM supplemented
with amino acids (KSOM+AA) under mineral oil (Ho et al., 1995).
To generate parthenogenetic embryos, MII eggs were activated
with 10 mM SrCl2 in Ca2+- and Mg2+-free CZB for 2.5 h and further
cultured in KSOM+AA, except in the experiment described in Fig. 2B
in which the eggs were cultured in the presence of SrCl2 for 6 h.
When necessary, cycloheximide (20 μg/ml) or MG132 (10 µM)
was added to the culture medium to inhibit protein synthesis or
proteasome-mediated protein degradation, respectively. All oocytes
and embryos were cultured at 37 °C in a humidiﬁed atmosphere of
5% CO2 in air.Immunoblotting
Oocytes, eggs or embryos were directly lysed in SDS-PAGE
sample buffer (100 mM Tris–HCl, pH 6.8, 200 mM dithiothreitol, 4%
SDS, 0.2% bromophenol blue, 20% glycerol), and stored at−20 °C until
use. The samples were boiled for 5 min prior to being subjected to
SDS-PAGE in a 12.5% gel. The proteins were then transferred to
Immobilon-P (Millipore, Bedford, MA), and the membranes were
blocked with 2–5% non-fatty milk in PBST (PBS with 0.2% Tween-20)
for 1 h at room temperature, or overnight at 4 °C. After blocking, the
membranes were washed twice in PBST for 10 min each and then
incubated with an anti-ORC6L antibody (1:100 dilution in PBST; Cell
Signaling Technology, Danvers, MA) overnight at 4 °C. Following
incubationwith the primary antibody, themembranes werewashed 3
times in PBST for 15 min each and then incubated with horseradish
peroxidase-conjugated secondary antibody (1:200,000 dilution;
Jackson ImmunoResearch Laboratories, West Grove, PA) for 1 h at
room temperature. After washing in PBST for 3 times (15 min each),
the membranes were developed using ECL Advance Western Blotting
System (GE Healthcare, Piscataway, NY). As a loading control,
membranes were stripped and reprobed with a mouse monoclonal
anti β-tubulin antibody (cat # T4026, Sigma, St. Louis, MO) at a
1:10,000 dilution.
Immunoﬂuorescence
Oocytes or eggs were ﬁxed in 2% paraformaldehyde for 20 min
at room temperature. The cells were permeabilized for 15 min in
PBS containing 0.1% Triton X-100, and blocked in PBS containing
0.1% BSA and 0.01% Tween-20 (blocking solution); they were then
incubated with the primary antibody for 1 h at room temperature
(1:100 dilution in blocking solution). After three washes in blocking
solution, the cells were incubated in the appropriate secondary
antibody for 1 h (Alexa Fluor 488-conjugated anti-rat IgG was
used [Invitrogen, Carlsbad, CA]). DNA was stained with 1.5 μg/ml
propidium iodide (Invitrogen). The cells were then washed and
mounted under a coverslip with gentle compression in VectaShield
antibleaching solution (Vector Laboratories, Burlingame, CA). Fluo-
rescence was detected on a Leica TCS SP laser-scanning confocal
microscope.
Preparation of double-stranded RNA (dsRNA)
Total RNA was isolated from 30 GV oocytes using the Picopure
RNA isolation kit (Arcturus, Sunnyvale, CA) according to the manu-
facturer's protocol. A reverse transcription (RT) reaction, primed with
oligo dT, was performed using Superscript II reverse transcriptase
(Invitrogen, Carlsbad, CA) following the manufacturer's instructions.
PCR was performed using this oocyte cDNA to generate the templates
for in vitro transcription. Two dsRNAswere used to targetOrc6lmRNA.
dsOrc6l corresponds to nucleotides 297 to 1085 (the entire coding
region) and dsUTR, to nucleotides 1086 to 1653 (the entire 3′ UTR) of
mouse Orc6l mRNA (accession number NM_019716.2). For ampliﬁ-
cation of the coding region of Orc6l, a pair of primers was designed
based on the cDNA sequence. The sequence of the upstream primer
was 5′-GCGATGGAGTCGGAGCTGG-3′ and the downstream primer
was 5′-TGCTGTGGCTGTCTGAG-3′. These primers generated a PCR
product that was 789 bp in length and corresponded to the entire
coding region of Orc6l. For ampliﬁcation of the 3′ UTR of Orc6l,
the following primers were used: upstream primer: 5′-TTTCCATCT-
CACTGCAGGCATG-3′, downstream primer: 5′-AATGTTTAAAAAA-
TATTTATTAACTTAGGC-3′. These primers generated a PCR product
that was 568 bp in length and corresponded to the entire 3′ UTR of
Orc6l. Both PCR products were cloned into pGEM-T Easy vector
(Promega, Madison, WI), the plasmids were digested and linearized
with FspI and served as template for in vitro transcription. Sense
Fig. 1. Maturation-associated increase in ORC6L protein. (A) Immunoblot analysis of
ORC6L in full-grown oocytes (GV), metaphase II eggs (MII), and one-cell embryos (1-cell).
The indicated numbers of cells were loaded per lane. The blot was stripped and reprobed
with an anti-β-tubulin antibody as a loading control. The experimentwas conducted three
times and shown is a representative immunoblot. (B) Immunoﬂuorescence detection of
ORC6L in full-grown oocytes (GV), metaphase II eggs (MII), and one-cell embryos (1-cell).
As a control, the primary antibodywas omitted in panel d. The experimentwas performed
three times and at least eight oocytes/embryos were analyzed in each experiment. Shown
are representative examples.
Fig. 2. Protein synthesis is required for accumulation of ORC6L. (A) ORC6L protein levels
were determined during oocyte maturation. Full-grown oocytes (GV) were collected
and in vitromatured in the absence (−) or presence of 10 µg/ml cycloheximide (CHX).
At the indicated times following removal of milrinone samples were collected for
immunoblotting. The immunoblots were performed as described under Materials and
Methods, using 10 oocytes per lane. The experiment was conducted three times and
shown is a representative example. (B) Stability of ORC6L protein in unfertilized eggs.
Metaphase II eggs (MII) were collected and incubated in CZB with (CHX) or without (–)
cycloheximide, cycloheximide and MG132 (CHX+MG) or MG132 alone (MG). Another
group of eggs was parthenogenetically activated with 10 mM SrCl2 and incubated for
6 h (Sr2+). ORC6L protein levels were determined by immunoblotting as described
above. The experiment was performed two times and similar results were obtained in
each case. A similar experiment without adding MG132 was conducted three times and
similar results to those shown here were obtained with respect to the extensive
degradation of ORC6L in the presence of cycloheximide. In these experiments, however,
the apparent increase in the amount of ORC6L in activated eggs when compared to
unactivated eggs was not always observed.
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MEGAscript kits (Ambion, Austin, TX) and mixed. After heating
at 75 °C for 5 min, the RNA was cooled and annealed slowly at room
temperature. The sample was treated with DNase I and RNase A, and
then puriﬁed twice by phenol chloroform extraction and ethanol
precipitation. Gfp dsRNA was prepared in the same way and used as a
control dsRNA for injections. The puriﬁed dsRNAs (1 mg/ml) were
stored at −20 °C.
DNA constructs, in vitro transcription, and site-directed mutagenesis
Mouse Orc6l 3′ UTR was prepared and cloned into pGEM-T
Easy vector as described above. Mouse ccb1 3′ UTR was ampliﬁed
by RT-PCR from mouse GV oocyte cDNA using an upstream primer
with a MfeI site (5′-CAATTGCTCCAATAGACTGCTACATCTGCA-3′) and
a downstream primer with a MfeI site (5′-CAATTGAAAGCTTTCCAC-
CAATAAATTTTAT-3′), which were designed based on the cDNA
sequence (accession number NM_172301). The PCR product was
cloned into pGEM-T Easy vector. pGEM-Orc6l 3′ UTR was digested
with EcoRI and pGEM-ccnb1 3′ UTR was digested with MfeI, and
each DNA fragment was cloned into a unique site in pIVT replacing
β-globin 3′-UTR. Fireﬂy luciferase was ampliﬁed from pGL3 (Pro-
mega) and cloned into the expression vector containing the 3′UTR of
Orc6l or Ccnb1. Renilla luciferase was ampliﬁed from pGL4.70 [hRluc]
(Promega) and cloned into pIVT vector (Igarashi et al., 2007). The
site-directedmutagenesis of CPEs or hexanucleotides in the 3′UTR of
Orc6l was performed by a procedure based on long PCR (Imai et al.,
1991). Complementary RNAs (cRNAs) of all constructs were syn-
thesized from linearized plasmid DNAs using T7 RNA polymerase
and the mMESSAGE mMACHINE kit (Ambion) according to the
manufacturer's instructions; the resulting cRNA contains 33 A
residues followed by 12 C residues at the 3′ end. The cRNA was
cleared and puriﬁed by phenol/chloroform extraction and isopro-
panol precipitation. The ﬁnal cRNA concentration was determined by
spectrophotometry, and cRNA integrity was conﬁrmed by analyzing
a sample on a formaldehyde gel.Microinjection
Injections were done in 10-μl drops of modiﬁedWhitten's medium
containing 15 mM HEPES, pH 7.2, 7 mM Na2HCO3, 10 μg/ml genta-
micin and 0.01% PVA containing 2.5 μM milrinone. Approximately
10 pl of dsRNA or cRNAwas injected into the cytoplasm of GV oocytes
using a PLI-100 Pico-Injector (Harvard Apparatus, Holliston, MA) on
the stage of a Nikon TE2000 microscope equipped with Hoffman
optics and Narishige micromanipulators.
BrdU incorporation assay
To detect DNA replication, embryos with a pronucleus were
labeled at 7 h after Sr2+ activation with 1 mM BrdU in KSOM+AA
for 30 min. The embryos were ﬁxed in 2.5% paraformaldehyde con-
taining 0.5 N NaOH for 15 min at room temperature, blocked and
permeabilized in PBS containing 10% FBS and 0.1% Triton X-100
for 30 min at 37 °C, and then washed with PBS containing 2% FBS
and 0.1% Triton X-100. BrdU incorporation to chromatin was
detected with mouse monoclonal antibody to bromodeoxyuridine
(1:20 dilution; Santa Cruz Biotechnology, Santa Cruz, CA) followed
by Alexa 546-conjugated goat anti-mouse IgG (1:100 dilution; cat. #
A-11003, Invitrogen). DNA was detected with 0.02% SITOX Green
(Invitrogen) for 15 min at room temperature. Embryos weremounted
in Vectashield (Vector Laboratories) and observed with a laser-
scanning confocal microscope.
Luciferase assay
The cRNAs of luciferasewithOrc6l or Ccnb1 3′UTR (10 pg/oocyte)
and Renilla luciferase (1.5 pg/oocyte) were co-injected into GV-
intact oocytes as described above and incubated in vitro for 16 hwith
or without maturation. Ten injected oocytes were collected and
incubated with Passive Lysis Buffer (1 μl/oocyte) for 15 min at room
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until luciferase activity was assayed using the Dual-Luciferase
Reporter Assay System (Promega) according to the manufacturer's
instructions except that 2 μl of sample and 20 μl of Luciferase Assay
Reagent II and of Stop & Glo Reagent were used. Signal intensities
were measured using a Monolight 2010 luminometer (Analytical
Luminescence Laboratory, San Diego, CA). Luciferase activities of
constructs with Orc6l 3′ UTR were normalized to that of Renilla
luciferase.Fig. 3. Functional analysis of the 3′ UTR of Orc6lmRNA. (A) Schematic depiction of the ﬁreﬂy
reading frame,β-globin 5′UTR, and the 3′UTR ofmouse cyclin B1 (Ccnb1) orOrc6l, including t
elements (CPEs). HEX(−):Orc6l cRNAwith apointmutation in theHEX; CPE1(−):Orc6l cRNA
the CPE proximal to the HEX has been mutated. Bold letters indicate the mutated nucleotid
containing ﬁreﬂy luciferase open reading frame and the 3′ UTR of either cyclin B1 (B1) or
maturation (GV) or theywere allowed to undergo in vitromaturation (IVM) prior to assaying fo
of three experiments. (C) Oocyteswere injectedwith each of the cRNAs depicted in (A), eith
were assayed as described in Materials and methods. Fireﬂy luciferase reporter activities
to the activity in oocytes injected with Orc6l mRNA, which was set to 1. The experiment wResults
Maturation-associated increase in ORC6L protein
Although oocytes contain Orc6l mRNA (data not shown), they
lack ORC6L protein as determined by both immunocytochemical and
immunoblotting approaches (Fig. 1); no signal was observed when
either 20 or 100 oocytes were used for immunoblotting. Oocyte
maturation was associated with a dramatic increase in the amount ofluciferase reporters used for microinjection. These cRNAs contain ﬁreﬂy luciferase open
he hexanucleotide polyadenylation element (HEX) and the cytoplasmic polyadenylation
inwhich the CPEdistant from theHEXhas beenmutated; CPE2(−):Orc6l cRNA inwhich
es in these constructs. (B) Full-grown mouse oocytes were microinjected with cRNAs
Orc6l. Microinjected oocytes were cultured for 16 h in conditions that prevent meiotic
r luciferase activity.−/GV: uninjected oocytes. The data are expressed as themean±SEM
er in vitromatured (IVM) or kept arrested at the GV stage (GV) and luciferase activities
were normalized to the co-injected Renilla luciferase control and are shown relative
as conducted three times and the data are presented as the mean±SEM.
Fig. 4. Orc6l knockdown abolishes DNA replication in parthenogenetically activated
eggs. (A) Full-grown mouse oocytes were microinjected with Orc6l dsRNA (dsOrc6l) or
GFP dsRNA (dsGFP) and in vitromatured (IVM) for 16 h. Twenty oocytes per treatment
were processed and analyzed by immunoblotting. The blot was stripped and reprobed
with an anti-β-tubulin antibody for loading control. GV: uninjected full-grown oocytes.
The experiment was conducted three times and a representative immunoblot is shown.
(B) Oocytes microinjected and in vitro matured as described in (A) were parthenoge-
netically activated with SrCl2. After activation, they were further cultured and then
processed for immunocytochemical detection of ORC6L (a, b); DNA was stained with
propidium iodide (a', b'). The merge images are also shown (a", b"). The experiment
was conducted three times using at least 5 oocytes per group and representative images
are shown. (C) dsRNA-injected oocytes were in vitro matured and parthenogenetically
activated as described above. Seven h after Sr2+ activation BrdU incorporation into
chromatin was assayed (a, b). DNA was stained with SYTOX Green (a', b'). The merge
images are also shown (a", b"). The experiment was conducted three times using at
least 10 oocytes per group and representative images are shown.
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normalized to the amount of β-tubulin, the amount of ORC6L protein
in 1-cell embryos is similar to that in MII eggs. ORC6L protein is
not detected in MII eggs by immunocytochemistry, even on the
chromosomes (Fig. 1B). The failure to detect by immunocytochem-
istry ORC6L protein in MII eggs could reﬂect the dispersion of the
protein in the cytoplasm below threshold detection. Alternatively, if
ORC6L as associated with the chromosomes, access of the antibody
may be precluded. As anticipated from the immunoblotting results,
ORC6L was readily detected in the pronuclei of 1-cell embryos
(Fig. 1B).
ORC6L protein starts to accumulate shortly after GVBD, progres-
sively accumulates during the course of maturation and requires
protein synthesis because addition of cycloheximide to the culture
medium prevents ORC6L accumulation (Fig. 2A). Protein synthesis is
also required to maintain the newly synthesized ORC6L protein in
MII-arrested eggs (Fig. 2B). Virtually no ORC6L was detected in MII
eggs cultured for 6 h in medium containing cycloheximide, whereas
the amount of ORC6L in control eggs was very similar to that present
inMII eggs before culture. Consistent with a relatively short half-life of
newly synthesized ORC6L recruited during meiotic maturation was
that the proteasome inhibitor MG132 (Tsubuki et al., 1993) prevented
the decrease in ORC6L when protein synthesis was inhibited and that
the amount of ORC6L protein increased in eggs incubated in the
presence of MG132 alone (Fig. 2B). Although the amount of ORC6L
protein appeared to increase following egg activation, in other
experiments this increase was not observed (see legend to Fig. 2B).
Orc6l mRNA is a dormant maternal mRNA recruited during oocyte
maturation
The absence of ORC6L protein in oocytes, coupled with the
maturation-associated increase is a hallmark of dormant maternal
mRNAs, e.g., Mos mRNA. Such maternally recruited mRNAs contain
one or more CPEs in their 3′ UTR that are typically situated within
a few hundred nucleotides of the hexanucleotide polyadenylation
element (HEX) (Oh et al., 2000; Pique et al., 2008; Richter, 1991).
Examination of the Orc6l mRNA sequence reveals that two potential
CPEs (UUUUAUU) reside 26 nucleotides and 53 nucleotides, respec-
tively, upstream from the AAUAA polyadenylation element.
To determine whether either or both of these potential CPEs were
responsible for the maturation-associated increase in ORC6L protein,
luciferase (Luc) mRNA reporter constructs that contained these CPEs in
the 3′ UTR were injected in oocytes (Fig. 3A). A cyclin B1 (Ccnb1)
reporter that contains one CPE was injected as a positive control. The
oocytes were then matured in vitro. Control oocytes were cultured for
the same amount of time in the presence of milrinone, which prevents
maturation (Tsafriri et al., 1996).Maturationwas clearly associatedwith
an increase in luciferase activity following injection of the Luc reporter
construct containing both Orc6l CPEs. As anticipated, there was also a
dramatic increase in luciferase activity following maturation of oocytes
injected with the reporter containing Ccnb1 CPEs (Fig. 3B).
To establish that the putative CPEs were indeed functional and if so,
what was the relative contribution of each CPE, Luc reporter constructs
containingmutations (UUUUAUU—NUUGGAUU) in each of theputative
CPEs were injected into oocytes (Fig. 3C). Results of these experiments
strongly implicate CPE2, the CPE closer to the polyadenylation element
as the CPE that is largely responsible for recruitment of Orc6lmRNA. In
all cases, a functional HEX was required for the maturation-associated
increase in luciferase activity (Fig. 3C).
Recruitment of maternal Orc6l mRNA during maturation is essential for
DNA replication in activated eggs
RNAi-mediated ablation of the dormant maternal Orc6lmRNAwas
used to establish whether the maturation-associated synthesis ofORC6L was required for DNA replication following egg activation.
Accordingly, oocytes were injected with dsRNA targeting endogenous
Orc6lmRNA and then matured in vitro; control oocytes were injected
with Gfp dsRNA. As expected, maturation of oocytes injected with
Orc6l dsRNA did not display an increase in ORC6L protein, whereas
such an increase was observed in Gfp dsRNA-injected cells (Fig. 4A).
Furthermore, following Sr2+ activation of the matured eggs, ORC6L
was readily detected in the pronucleus of the Gfp dsRNA-, but not
Orc6l dsRNA-, injected eggs (Fig. 4B). Thus, RNAi-mediated targeting
of Orc6l mRNA effectively inhibited the maturation-associated
increase in ORC6L protein. Furthermore, Sr2+-activated eggs in
which accumulation of ORC6L protein was inhibited by RNAi dis-
played a virtual absence of BrdU incorporation in contrast to their
Gfp dsRNA-injected counterparts (Fig. 4C), a result consistent with
inhibiting DNA replication in ORC6L-depleted eggs.
It was formally possible that the observed inhibition of DNA
synthesis in ORC6L-depleted activated eggs was due to off-targeting
effects in response to the Orc6l dsRNA. Results of a rescue experiment
strongly suggest that this was an unlikely scenario. Oocytes were co-
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the maturation-associated increase in ORC6L protein) and an Orc6l-
encoding cRNA. This cRNA cannot be targeted by the siRNAs gen-
erated from the dsRNA directed to the 3′ UTR of Orc6l and thereby
enhances the likelihood of observing a rescue. Controls were injected
with Gfp dsRNA. Following maturation and Sr2+-activation BrdU
incorporationwas determined. As anticipated, activated eggs inwhich
the maturation-associated increase in ORC6L was inhibited displayed
reduced BrdU incorporation when compared to controls and incor-
poration was fully restored following injection of Orc6l cRNA (Fig. 5A
and B).
We noted that in contrast to the virtual total abolition of BrdU
incorporation when a dsRNA directed towards the coding region of
Orc6l was used (see Fig. 4), detectable BrdU incorporation was
observed when a dsRNA directed towards the 3′ UTR was used. TheFig. 5. Orc6lmRNA can rescue the DNA replication failure of ORC6L knockdown oocytes. (A)
(dsUTR) or GFP dsRNA (dsGFP). A third group of oocytes was co-injected with dsUTR and
(rescue). All microinjected oocytes were in vitromatured and parthenogenetically activated
assayed; DNA was stained with SYTOX Green. The experiment was conducted three times
are shown. (B) BrdU incorporation in the three groups of microinjected oocytes described
intensity in each nucleus was measured and the background value (an area of the cytoplasm
La Jolla, CA). Comparisons among groups were done using one-way ANOVA, followed by Bonf
to the mean ﬂuorescence intensity of GFP dsRNA-injected oocytes. (C) Full-grown mouse o
oocytes per treatment were processed and analyzed by immunoblotting. The blot was strip
was conducted three times and a representative immunoblot is shown.likely basis for this observation was that the dsRNA directed towards
the 3′ UTR of Orc6l was less effective in inhibiting the maturation-
associated increase in ORC6L protein (Fig. 5C). This difference
presumably reﬂects differences in accessibility of the siRNAs for
their cognate binding sequences.
Discussion
We report here that mouse oocytes lack detectable amounts
of ORC6L, which is synthesized during oocyte maturation due to re-
cruitment of Orc6lmRNA and that the maturation-associated synthesis
of ORC6L protein is required to establishDNA replication competence in
the 1-cell embryo. Thus, mouse oocytes lack at least two components
required for preRC formation and ORI licensing, i.e., ORC6L and CDC6.
Preliminary immunoblotting and immunocytochemical studies indicateFull-grown mouse oocytes were microinjected with a dsRNA against the 3′ UTR of Orc6l
a cRNA that contains the coding sequence of Orc6l and the 5′ and 3′ UTR of β-globin
with 10 mM SrCl2. Seven h after Sr2+ activation BrdU incorporation into chromatin was
in which at least 10 cells with a PN per group were analyzed; representative images
in (A) was quantiﬁed using ImageJ software (http://rsb.info.nih.gov/ij). Fluorescence
of equal size) was subtracted. The data were analyzed using Prism (GraphPad Software,
erroni post-test. *, Pb0.05. The results are expressed as themean±SEM and normalized
ocytes were microinjected with dsUTR or dsGFP and in vitro matured for 16 h. Twenty
ped and reprobed with an anti-β-tubulin antibody for loading control. The experiment
211S. Murai et al. / Developmental Biology 341 (2010) 205–212that oocytes contain all of the other proteins of the ORI complex, i.e.,
ORC1, 2, 3 L, 4 L, and 5 L, aswell as all sixmembers of theMCMcomplex,
i.e., MCM2–7 (unpublished observations) and previous studies docu-
mented the presence of MCM2, 6, and 7 (Lemaitre et al., 2004; Swiech
et al., 2007). In addition, proteins involved in recruiting MCM and
initiating DNA replication (CDT1, CDC7, CDC45, and MCM10) and
regulating licensing, e.g., GMN (Lei and Tye, 2001), are also present
(unpublished observations).
The observation that at least two components required for DNA
replication are not present in mouse oocytes but synthesized during
oocyte maturation contrasts to Xenopus in which CDC6 appears to be
the only preRC and licensing component missing in the fully grown
oocyte (Lemaitre et al., 2002; Whitmire et al., 2002). In Xenopus,
recruitment of Cdc6 mRNA during maturation provides the
missing ORI protein and high levels of CDK1/CDC2A activity in the
metaphase II egg inhibit licensing of the ORI. That at least two
components—CDC6 and ORC6L—required to license DNA replication
are missing in mouse oocytes may reﬂect an evolutionary selective
pressure to minimize precocious DNA replication either during matu-
ration or following arrest at metaphase II in species that ovulate only
a few eggs; premature DNA replication would clearly compromise
reproductive ﬁtness. This constraint may not be as severe in species
such as Xenopus that ovulate thousands of eggs.
The presence of the ORC on chromosomes as a function of the cell
cycle depends on the species (DePamphilis, 2003). In yeast, ORC
remain associated with chromatin throughout the course of the cell
cycle. In contrast, in metazoans, ORCs display cell cycle changes in
chromosome association, namely, disengaging during S phase and
dissociating during entry into M phase. Our not detecting ORC6L
on metaphase II chromosomes is consistent with ORCs dissociating
from chromosomes during entry into metaphase. The best evidence
that ORCs do not associate with metaphase chromosomes in higher
eukaryotes comes from experiments that examined Orc2 localization
during early Drosophila embryogenesis (Baldinger and Gossen,
2009). In that study a transgenic line was developed that expressed
an Orc2-GFP fusion protein to the same level as endogenous Orc2 and
furthermore integrated into an ORC as efﬁciently as endogenous Orc2.
Thus, GFP localization accurately reﬂects ORC localization. ORC was
highly enriched in the nucleus during interphase, absent from meta-
phase chromosomes, and only appeared on chromosomes following
entry into anaphase in response to a decrease in CDK activity.
The likely absence of ORCs on chromosomes of eggs arrested at
metaphase II ensures that precocious DNA replication cannot occur.
Orc6l mRNA is a newly identiﬁed dormant maternal mRNA in
mouse oocytes. Recruitment of maternal mRNAs is governed by the
presence of a CPE in the 3′ UTR and Orc6l mRNA contains two CPEs
identiﬁed by their sequence. Results from our functional studies
indicate that the CPE closest to the polyadenylation element confers
the ability of Orc6l mRNA to be recruited. In contrast to Mos mRNA
whose recruitment is also coupled with its degradation (Medvedev
et al., 2008), our microarray data suggest that recruitment of Orc6l
mRNA is not coupled with its degradation. ORC6L protein appears
fairly unstable, based on its rapid decrease in abundancewhen protein
synthesis is inhibited in MII eggs, and this instability may be the
driving force to uncouple recruitment of Orc6l mRNA with its degra-
dation. Fertilization does not appear to stimulate ORC6L synthesis,
which is consistent with Orc6l mRNA lacking any polyuridine tract
that is associated with mRNA recruitment following fertilization, e.g.,
dodecauridine (Simon and Richter, 1994; Simon et al., 1992).
Other components of the ORC and licensing machinery have
putative CPEs, e.g. Mcm2, 4, and 7, Cdc45, and Cdt1, suggesting that
they too could be recruited during maturation. Interestingly, in con-
trast to ORC6L (and CDC6), these proteins are already readily
detectable in the oocyte based on immunocytochemical and immu-
noblotting analyses. A maturation-associated increase in these com-
ponents could be important for DNA replication in a fashion similar tothe IP3 receptor protein, which is present in oocytes and displays a
maturation-associated increase that confers increased sensitivity to
IP3-mediated calcium release (Xu et al., 2003). Whether these mRNAs
that encode other components of the ORC and licensing apparatus are
recruited during maturation and whether such recruitment is
necessary for DNA replication following fertilization is not known.
Nevertheless, what emerges is a general theme that several compo-
nents required to initiate DNA replication in 1-cell embryos are up-
regulated during oocyte maturation in preparation for fertilization.
In S. cerevisiae ORC6, although not required for DNA binding, is
essential for DNA replication, presumably because of failure to recruit
CDT1 and hence facilitate loading of theMCM2–7 helicase (Chen et al.,
2007). Results in other species and cell types suggest that ORC6 is also
essential for DNA replication. Although early evidence pointed to a
defect in cytokinesis rather than DNA replication in Orc6 mutants
(Chesnokov et al., 2003; Prasanth et al., 2002), more recent ﬁndings
pinpoint a role of the N-terminal domain in DNA replication, whereas
the C-terminal domain appears critical to traverse M phase (Balasov
et al., 2009). In contrast, results of experiments using Xenopus egg
extracts led to the conclusion that ORC6 is not required for initiation
of DNA replication (Gillespie et al., 2001). In Xenopus, ORC6 is loosely
associated with ORC1–5 because ORC6 is absent from puriﬁed ORC,
which is composed of ORC1–5. The puriﬁed complex can stimulate
DNA synthesis and hence replication licensing in a reconstituted
system using activated Xenopus egg extracts and sperm nuclei. The
presence of ORC6 in the egg extract, however, could account for
the ability of ORC1–5 to stimulate DNA replication; the concentra-
tion of ORC components in Xenopus eggs is extraordinarily high
(DePamphilis, 2005). Our results strongly suggest that ORC6L is
required to initiate DNA replication in 1-cell mouse embryos be-
cause preventing the maturation-associated synthesis of ORC6L
results in 1-cell embryos that cannot support DNA replication.
Whether this is a unique feature of mammalian zygotes or truly
reﬂects a more universal requirement for ORC6L in initiation of DNA
replication remains an open question.Acknowledgments
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